Ligand profile
KV5
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00667 — Glycogen phosphorylase
Identifiers
Database identifiers and provenance.
- Ligand ID
KV5- PDB
6s4o- UniProt (similar protein)
P00489- Target protein
- KP13_00667
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 118.8
- −1 ≤ LogP ≤ 5 0.74
- MW ≤ 500 Da 356.4
- LogP ≤ 5 0.74
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 118.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc2cc(ccc2c1)c3[nH]cc(n3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)Oc1ccc2cc(ccc2c1)c3[nH]cc(n3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O
InChI=1S/C19H20N2O5/c22-9-14-15(23)16(24)17(25)18(26-14)13-8-20-19(21-13)12-6-5-10-3-1-2-4-11(10)7-12/h1-8,14-18,22-25H,9H2,(H,20,21)/t14-,15-,16+,17-,18+/m1/s1InChI=1S/C19H20N2O5/c22-9-14-15(23)16(24)17(25)18(26-14)13-8-20-19(21-13)12-6-5-10-3-1-2-4-11(10)7-12/h1-8,14-18,22-25H,9H2,(H,20,21)/t14-,15-,16+,17-,18+/m1/s1
VRUXFQSZTNCMBM-SFFUCWETSA-NVRUXFQSZTNCMBM-SFFUCWETSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00343
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand KV5 →
- PDB RCSB structure 6s4o →
- UniProt UniProt P00489 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “KV5”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00667.
PDB 115
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).